| Título : |
C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms |
| Tipo de documento : |
documento electrónico |
| Autores : |
Marcos Arango Barrientos, ; Juan Felipe Combariza Vallejo, |
| Fecha de publicación : |
2014 |
| Títulos uniformes : |
Supportive Care in Cancer
|
| Idioma : |
Inglés (eng) |
| Palabras clave : |
Febrile neutropenia C-reactive protein hematologic neoplasms |
| Resumen : |
Objective: The objective of this study is to assess the prognostic usefulness of the Multinational Association of Supportive Care in Cancer (MASCC) risk score in association with the value of C-reactive protein (CRP) to identify high-risk patients with febrile neutropenia and hematologic neoplasms. Methods: A retrospective cohort study in which the MASCC score and the CRP values were used to assess the mortality risk at 30 days among patients with febrile neutropenia and hematologic malignancies was performed. Results: Two hundred thiry-seven patients with febrile neutropenia were analyzed; the mortality rate within 30 days was 9 %. High-risk patients according to the MASCC score were significantly more likely to experience adverse outcomes, such as being transferred to the intensive care unit (RR 3.55; CI 95 % 2.73–6.62, p |
| Mención de responsabilidad : |
Juan F Combariza, Milton Lombana, Luis E Pino, Marcos Arango |
| Referencia : |
Support Care Cancer. 2015 Apr;23(4):1009-13. |
| DOI (Digital Object Identifier) : |
10.1007/s00520-014-2454-2 |
| PMID : |
25270848 |
| En línea : |
https://link.springer.com/article/10.1007%2Fs00520-014-2454-2 |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis |
Inicio
C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms
